Skip to main content
PMC home page
The EMBO Journal logoLink to The EMBO Journal
. 1997 Jul 1;16(13):3987–3994. doi: 10.1093/emboj/16.13.3987

Cells strongly expressing Ig(kappa) transgenes show clonal recruitment of hypermutation: a role for both MAR and the enhancers.

B Goyenechea 1, N Klix 1, J Yélamos 1, G T Williams 1, A Riddell 1, M S Neuberger 1, C Milstein 1
PMCID: PMC1170022  PMID: 9233808

Abstract

The V regions of immunoglobulin kappa transgenes are targets for hypermutation in germinal centre B cells. We show by use of modified transgenes that the recruitment of hypermutation is substantially impaired by deletion of the nuclear matrix attachment region (MAR) which flanks the intron-enhancer (Ei). Decreased mutation is also obtained if Ei, the core region of the kappa3'-enhancer (E3') or the E3'-flank are removed individually. A broad correlation between expression and mutation is indicated not only by the fact that the deletions affecting mutation also give reduced transgene expression, but especially by the finding that, within a single mouse, transgene mutation was considerably reduced in germinal centre B cells that poorly expressed the transgene as compared with strongly expressing cells. We also observed that the diminished mutation in transgenes carrying regulatory element deletions was manifested by an increased proportion of B cells in which the transgene had not been targeted at all for mutation rather than in the extent of mutation accumulation once targeted. Since mutations appear to be incorporated stepwise, the results point to a connection between transcription initiation and the clonal recruitment of hypermutation, with hypermutation being more fastidious than transcription in requiring the presence of a full complement of regulatory elements.

Full Text

The Full Text of this article is available as a PDF (453.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Betz A. G., Milstein C., González-Fernández A., Pannell R., Larson T., Neuberger M. S. Elements regulating somatic hypermutation of an immunoglobulin kappa gene: critical role for the intron enhancer/matrix attachment region. Cell. 1994 Apr 22;77(2):239–248. doi: 10.1016/0092-8674(94)90316-6. [DOI] [PubMed] [Google Scholar]
  2. Cockerill P. N., Garrard W. T. Chromosomal loop anchorage of the kappa immunoglobulin gene occurs next to the enhancer in a region containing topoisomerase II sites. Cell. 1986 Jan 31;44(2):273–282. doi: 10.1016/0092-8674(86)90761-0. [DOI] [PubMed] [Google Scholar]
  3. Cockerill P. N., Yuen M. H., Garrard W. T. The enhancer of the immunoglobulin heavy chain locus is flanked by presumptive chromosomal loop anchorage elements. J Biol Chem. 1987 Apr 15;262(11):5394–5397. [PubMed] [Google Scholar]
  4. Forrester W. C., van Genderen C., Jenuwein T., Grosschedl R. Dependence of enhancer-mediated transcription of the immunoglobulin mu gene on nuclear matrix attachment regions. Science. 1994 Aug 26;265(5176):1221–1225. doi: 10.1126/science.8066460. [DOI] [PubMed] [Google Scholar]
  5. González-Fernández A., Milstein C. Analysis of somatic hypermutation in mouse Peyer's patches using immunoglobulin kappa light-chain transgenes. Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):9862–9866. doi: 10.1073/pnas.90.21.9862. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Gorman J. R., van der Stoep N., Monroe R., Cogne M., Davidson L., Alt F. W. The Ig(kappa) enhancer influences the ratio of Ig(kappa) versus Ig(lambda) B lymphocytes. Immunity. 1996 Sep;5(3):241–252. doi: 10.1016/s1074-7613(00)80319-2. [DOI] [PubMed] [Google Scholar]
  7. Goyenechea B., Milstein C. Modifying the sequence of an immunoglobulin V-gene alters the resulting pattern of hypermutation. Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):13979–13984. doi: 10.1073/pnas.93.24.13979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hanawalt P. C. DNA repair comes of age. Mutat Res. 1995 Mar;336(2):101–113. doi: 10.1016/0921-8777(94)00061-a. [DOI] [PubMed] [Google Scholar]
  9. Imler J. L., Lemaire C., Wasylyk C., Wasylyk B. Negative regulation contributes to tissue specificity of the immunoglobulin heavy-chain enhancer. Mol Cell Biol. 1987 Jul;7(7):2558–2567. doi: 10.1128/mcb.7.7.2558. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Jolly C. J., Klix N., Neuberger M. S. Rapid methods for the analysis of immunoglobulin gene hypermutation: application to transgenic and gene targeted mice. Nucleic Acids Res. 1997 May 15;25(10):1913–1919. doi: 10.1093/nar/25.10.1913. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kepler T. B., Perelson A. S. Cyclic re-entry of germinal center B cells and the efficiency of affinity maturation. Immunol Today. 1993 Aug;14(8):412–415. doi: 10.1016/0167-5699(93)90145-B. [DOI] [PubMed] [Google Scholar]
  12. Lichtenstein M., Keini G., Cedar H., Bergman Y. B cell-specific demethylation: a novel role for the intronic kappa chain enhancer sequence. Cell. 1994 Mar 11;76(5):913–923. doi: 10.1016/0092-8674(94)90365-4. [DOI] [PubMed] [Google Scholar]
  13. Max E. E., Maizel J. V., Jr, Leder P. The nucleotide sequence of a 5.5-kilobase DNA segment containing the mouse kappa immunoglobulin J and C region genes. J Biol Chem. 1981 May 25;256(10):5116–5120. [PubMed] [Google Scholar]
  14. Meyer K. B., Ireland J. Activation of the immunoglobulin kappa 3' enhancer in pre-B cells correlates with the suppression of a nuclear factor binding to a sequence flanking the active core. Nucleic Acids Res. 1994 May 11;22(9):1576–1582. doi: 10.1093/nar/22.9.1576. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Meyer K. B., Neuberger M. S. The immunoglobulin kappa locus contains a second, stronger B-cell-specific enhancer which is located downstream of the constant region. EMBO J. 1989 Jul;8(7):1959–1964. doi: 10.1002/j.1460-2075.1989.tb03601.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Meyer K. B., Sharpe M. J., Surani M. A., Neuberger M. S. The importance of the 3'-enhancer region in immunoglobulin kappa gene expression. Nucleic Acids Res. 1990 Oct 11;18(19):5609–5615. doi: 10.1093/nar/18.19.5609. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Meyer K. B., Teh Y. M., Neuberger M. S. The Ig kappa 3'-enhancer triggers gene expression in early B lymphocytes but its activity is enhanced on B cell activation. Int Immunol. 1996 Oct;8(10):1561–1568. doi: 10.1093/intimm/8.10.1561. [DOI] [PubMed] [Google Scholar]
  18. Neuberger M. S., Milstein C. Somatic hypermutation. Curr Opin Immunol. 1995 Apr;7(2):248–254. doi: 10.1016/0952-7915(95)80010-7. [DOI] [PubMed] [Google Scholar]
  19. Peters A., Storb U. Somatic hypermutation of immunoglobulin genes is linked to transcription initiation. Immunity. 1996 Jan;4(1):57–65. doi: 10.1016/s1074-7613(00)80298-8. [DOI] [PubMed] [Google Scholar]
  20. Picard D., Schaffner W. A lymphocyte-specific enhancer in the mouse immunoglobulin kappa gene. Nature. 1984 Jan 5;307(5946):80–82. doi: 10.1038/307080a0. [DOI] [PubMed] [Google Scholar]
  21. Pongubala J. M., Atchison M. L. Functional characterization of the developmentally controlled immunoglobulin kappa 3' enhancer: regulation by Id, a repressor of helix-loop-helix transcription factors. Mol Cell Biol. 1991 Feb;11(2):1040–1047. doi: 10.1128/mcb.11.2.1040. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Queen C., Stafford J. Fine mapping of an immunoglobulin gene activator. Mol Cell Biol. 1984 Jun;4(6):1042–1049. doi: 10.1128/mcb.4.6.1042. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Rogerson B., Hackett J., Jr, Peters A., Haasch D., Storb U. Mutation pattern of immunoglobulin transgenes is compatible with a model of somatic hypermutation in which targeting of the mutator is linked to the direction of DNA replication. EMBO J. 1991 Dec;10(13):4331–4341. doi: 10.1002/j.1460-2075.1991.tb05011.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Roque M. C., Smith P. A., Blasquez V. C. A developmentally modulated chromatin structure at the mouse immunoglobulin kappa 3' enhancer. Mol Cell Biol. 1996 Jun;16(6):3138–3155. doi: 10.1128/mcb.16.6.3138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Scheuermann R. H., Chen U. A developmental-specific factor binds to suppressor sites flanking the immunoglobulin heavy-chain enhancer. Genes Dev. 1989 Aug;3(8):1255–1266. doi: 10.1101/gad.3.8.1255. [DOI] [PubMed] [Google Scholar]
  26. Sharpe M. J., Milstein C., Jarvis J. M., Neuberger M. S. Somatic hypermutation of immunoglobulin kappa may depend on sequences 3' of C kappa and occurs on passenger transgenes. EMBO J. 1991 Aug;10(8):2139–2145. doi: 10.1002/j.1460-2075.1991.tb07748.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Springer T. A., Bhattacharya A., Cardoza J. T., Sanchez-Madrid F. Monoclonal antibodies specific for rat IgG1, IgG2a, and IgG2b subclasses, and kappa chain monotypic and allotypic determinants: reagents for use with rat monoclonal antibodies. Hybridoma. 1982;1(3):257–273. doi: 10.1089/hyb.1.1982.1.257. [DOI] [PubMed] [Google Scholar]
  28. Storb U. The molecular basis of somatic hypermutation of immunoglobulin genes. Curr Opin Immunol. 1996 Apr;8(2):206–214. doi: 10.1016/s0952-7915(96)80059-8. [DOI] [PubMed] [Google Scholar]
  29. Weill J. C., Reynaud C. A. Rearrangement/hypermutation/gene conversion: when, where and why? Immunol Today. 1996 Feb;17(2):92–97. doi: 10.1016/0167-5699(96)80586-x. [DOI] [PubMed] [Google Scholar]
  30. Xu M., Hammer R. E., Blasquez V. C., Jones S. L., Garrard W. T. Immunoglobulin kappa gene expression after stable integration. II. Role of the intronic MAR and enhancer in transgenic mice. J Biol Chem. 1989 Dec 15;264(35):21190–21195. [PubMed] [Google Scholar]
  31. Xu Y., Davidson L., Alt F. W., Baltimore D. Deletion of the Ig kappa light chain intronic enhancer/matrix attachment region impairs but does not abolish V kappa J kappa rearrangement. Immunity. 1996 Apr;4(4):377–385. doi: 10.1016/s1074-7613(00)80251-4. [DOI] [PubMed] [Google Scholar]
  32. Yelton D. E., Desaymard C., Scharff M. D. Use of monoclonal anti-mouse immunoglobulin to detect mouse antibodies. Hybridoma. 1981;1(1):5–11. doi: 10.1089/hyb.1.1981.1.5. [DOI] [PubMed] [Google Scholar]
  33. Yélamos J., Klix N., Goyenechea B., Lozano F., Chui Y. L., González Fernández A., Pannell R., Neuberger M. S., Milstein C. Targeting of non-Ig sequences in place of the V segment by somatic hypermutation. Nature. 1995 Jul 20;376(6537):225–229. doi: 10.1038/376225a0. [DOI] [PubMed] [Google Scholar]

Articles from The EMBO Journal are provided here courtesy of Nature Publishing Group

RESOURCES